Biotech Law Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Biotech Law Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Catholic University of Rome, Italy
Thrombus burden is reduced and coronary flow improved with Diver C.E.
August 18th, 2006
The Diver C.E. is a rapid-exchange thrombus-aspirating catheter that is able to reduce thrombus burden and to improve coronary flow in patients with thrombus-containing lesions. A recent report out of Italy notes, "In patients with acute coronary syndromes (ACS), distal embolization of thrombotic material is more likely to play a key role in the pathogenesis of myocardial no-reflow during percutaneous coronary intervention (PCI). Thus, interventional techniques able to reduce thrombus burden at the culprit vessel might improve final myocardial reperfusion." F. Burzotta and colleagues at Catholic University in Rome explained that the aim of the study...
Source: Biotech Law Weekly (2006-08-18)
|
